Report Detail
Global (United States, European Union and China) Leuprolide Acetate Market Research Report 2019-2025
- RnM3648382 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Leuprolide acetate is a synthetic nonapeptide that is a potent gonadotropin-releasing hormone receptor (GnRHR) agonist used for diverse clinical applications, including the treatment of prostate cancer, endometriosis, uterine fibroids, central precocious puberty and in vitro fertilization techniques. Leuprolide acetate is given by injection into a muscle or under the skin.
Leuprorelin was approved for medical use in the United States in 1985. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. In the United Kingdom a monthly dose costs the NHS about 75.24 pounds. In the United States the equivalent dose has a wholesale cost of 1,011.93 USD.
In 2019, the market size of Leuprolide Acetate is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Leuprolide Acetate.
This report studies the global market size of Leuprolide Acetate, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Leuprolide Acetate sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Tolmar Pharmaceuticals
Varian Pharmed
Avenit
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Livzon Pharmaceutical
Beijing Biote Pharmaceutical
Soho-YImIng
AbbVie
Sanofi
Astellas Pharma
Abbott
Merck
Pfizer
Market Segment by Product Type
Intramuscular
Subcutaneous
Market Segment by Application
Prostate Cancer
Precocious
Uterine Fibroid
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Leuprolide Acetate status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Leuprolide Acetate manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Leuprolide Acetate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Leuprolide Acetate Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Intramuscular
- 1.3.3 Subcutaneous
- 1.4 Market Segment by Application
- 1.4.1 Global Leuprolide Acetate Market Share by Application (2019-2025)
- 1.4.2 Prostate Cancer
- 1.4.3 Precocious
- 1.4.4 Uterine Fibroid
- 1.4.5 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Leuprolide Acetate Market Size
- 2.1.1 Global Leuprolide Acetate Revenue 2014-2025
- 2.1.2 Global Leuprolide Acetate Sales 2014-2025
- 2.2 Leuprolide Acetate Growth Rate by Regions
- 2.2.1 Global Leuprolide Acetate Sales by Regions 2014-2019
- 2.2.2 Global Leuprolide Acetate Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Leuprolide Acetate Sales by Manufacturers
- 3.1.1 Leuprolide Acetate Sales by Manufacturers 2014-2019
- 3.1.2 Leuprolide Acetate Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Leuprolide Acetate Revenue by Manufacturers (2014-2019)
- 3.2.2 Leuprolide Acetate Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Leuprolide Acetate Market Concentration Ratio (CR5 and HHI)
- 3.3 Leuprolide Acetate Price by Manufacturers
- 3.4 Key Manufacturers Leuprolide Acetate Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Leuprolide Acetate Market
- 3.6 Key Manufacturers Leuprolide Acetate Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Intramuscular Sales and Revenue (2014-2019)
- 4.1.2 Subcutaneous Sales and Revenue (2014-2019)
- 4.2 Global Leuprolide Acetate Sales Market Share by Type
- 4.3 Global Leuprolide Acetate Revenue Market Share by Type
- 4.4 Leuprolide Acetate Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Leuprolide Acetate Sales by Application
6 United States
- 6.1 United States Leuprolide Acetate Breakdown Data by Company
- 6.2 United States Leuprolide Acetate Breakdown Data by Type
- 6.3 United States Leuprolide Acetate Breakdown Data by Application
7 European Union
- 7.1 European Union Leuprolide Acetate Breakdown Data by Company
- 7.2 European Union Leuprolide Acetate Breakdown Data by Type
- 7.3 European Union Leuprolide Acetate Breakdown Data by Application
8 China
- 8.1 China Leuprolide Acetate Breakdown Data by Company
- 8.2 China Leuprolide Acetate Breakdown Data by Type
- 8.3 China Leuprolide Acetate Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Leuprolide Acetate Breakdown Data by Company
- 9.2 Rest of World Leuprolide Acetate Breakdown Data by Type
- 9.3 Rest of World Leuprolide Acetate Breakdown Data by Application
- 9.4 Rest of World Leuprolide Acetate Breakdown Data by Countries
- 9.4.1 Rest of World Leuprolide Acetate Sales by Countries
- 9.4.2 Rest of World Leuprolide Acetate Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Tolmar Pharmaceuticals
- 10.1.1 Tolmar Pharmaceuticals Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Leuprolide Acetate
- 10.1.4 Leuprolide Acetate Product Introduction
- 10.1.5 Tolmar Pharmaceuticals Recent Development
- 10.2 Varian Pharmed
- 10.2.1 Varian Pharmed Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Leuprolide Acetate
- 10.2.4 Leuprolide Acetate Product Introduction
- 10.2.5 Varian Pharmed Recent Development
- 10.3 Avenit
- 10.3.1 Avenit Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Leuprolide Acetate
- 10.3.4 Leuprolide Acetate Product Introduction
- 10.3.5 Avenit Recent Development
- 10.4 Takeda Pharmaceutical
- 10.4.1 Takeda Pharmaceutical Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Leuprolide Acetate
- 10.4.4 Leuprolide Acetate Product Introduction
- 10.4.5 Takeda Pharmaceutical Recent Development
- 10.5 Sun Pharmaceutical Industries
- 10.5.1 Sun Pharmaceutical Industries Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Leuprolide Acetate
- 10.5.4 Leuprolide Acetate Product Introduction
- 10.5.5 Sun Pharmaceutical Industries Recent Development
- 10.6 Livzon Pharmaceutical
- 10.6.1 Livzon Pharmaceutical Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Leuprolide Acetate
- 10.6.4 Leuprolide Acetate Product Introduction
- 10.6.5 Livzon Pharmaceutical Recent Development
- 10.7 Beijing Biote Pharmaceutical
- 10.7.1 Beijing Biote Pharmaceutical Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Leuprolide Acetate
- 10.7.4 Leuprolide Acetate Product Introduction
- 10.7.5 Beijing Biote Pharmaceutical Recent Development
- 10.8 Soho-YImIng
- 10.8.1 Soho-YImIng Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Leuprolide Acetate
- 10.8.4 Leuprolide Acetate Product Introduction
- 10.8.5 Soho-YImIng Recent Development
- 10.9 AbbVie
- 10.9.1 AbbVie Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Leuprolide Acetate
- 10.9.4 Leuprolide Acetate Product Introduction
- 10.9.5 AbbVie Recent Development
- 10.10 Sanofi
- 10.10.1 Sanofi Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Leuprolide Acetate
- 10.10.4 Leuprolide Acetate Product Introduction
- 10.10.5 Sanofi Recent Development
- 10.11 Astellas Pharma
- 10.12 Abbott
- 10.13 Merck
- 10.14 Pfizer
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Leuprolide Acetate Sales Channels
- 11.2.2 Leuprolide Acetate Distributors
- 11.3 Leuprolide Acetate Customers
12 Market Forecast
- 12.1 Global Leuprolide Acetate Sales and Revenue Forecast 2019-2025
- 12.2 Global Leuprolide Acetate Sales Forecast by Type
- 12.3 Global Leuprolide Acetate Sales Forecast by Application
- 12.4 Leuprolide Acetate Forecast by Regions
- 12.4.1 Global Leuprolide Acetate Sales Forecast by Regions 2019-2025
- 12.4.2 Global Leuprolide Acetate Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Leuprolide Acetate. Industry analysis & Market Report on Leuprolide Acetate is a syndicated market report, published as Global (United States, European Union and China) Leuprolide Acetate Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Leuprolide Acetate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
